Next, we performed an in vivo experiment to investigate the effects of PDK1 modulation on tumor growth and metabolism: shPDK1 or shRNA tumor cells from OVCAR and OC316 cell lines were injected subcutaneously in SCID mice (n = 4 mice/group). The gene discussed is PDK1; the disease is neoplasm.